Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

SILO

Silo Pharma (QB) (SILO)

Silo Pharma Inc (QB)
Von:
Sortieren nach:
 Showing the most relevant articles for your search:USOTC:SILO
DatumZeitQuelleÜberschriftSymbolFirma
29/06/202322h32Edgar (US Regulatory)Current Report Filing (8-k)USOTC:SILOSilo Pharma Inc (QB)
26/05/202322h20Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:SILOSilo Pharma Inc (QB)
18/05/202322h21Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:SILOSilo Pharma Inc (QB)
15/02/202322h17Edgar (US Regulatory)Current Report Filing (8-k)USOTC:SILOSilo Pharma Inc (QB)
14/02/202322h01Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:SILOSilo Pharma Inc (QB)
03/02/202314h01Edgar (US Regulatory)Current Report Filing (8-k)USOTC:SILOSilo Pharma Inc (QB)
31/01/202322h16Edgar (US Regulatory)Current Report Filing (8-k)USOTC:SILOSilo Pharma Inc (QB)
20/01/202314h01Edgar (US Regulatory)Current Report Filing (8-k)USOTC:SILOSilo Pharma Inc (QB)
15/12/202222h16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:SILOSilo Pharma Inc (QB)
01/12/202222h17Edgar (US Regulatory)Current Report Filing (8-k)USOTC:SILOSilo Pharma Inc (QB)
10/11/202222h49Edgar (US Regulatory)Quarterly Report (10-q)USOTC:SILOSilo Pharma Inc (QB)
18/10/202223h16Edgar (US Regulatory)Current Report Filing (8-k)USOTC:SILOSilo Pharma Inc (QB)
30/09/202214h46Edgar (US Regulatory)Current Report Filing (8-k)USOTC:SILOSilo Pharma Inc (QB)
28/09/202222h35Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)USOTC:SILOSilo Pharma Inc (QB)
27/09/202214h30Edgar (US Regulatory)Certification by the Exchange Approving Securities for Listing (cert)USOTC:SILOSilo Pharma Inc (QB)
27/09/202212h03Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:SILOSilo Pharma Inc (QB)
26/09/202222h01Edgar (US Regulatory)Securities Registration (section 12(b)) (8-a12b)USOTC:SILOSilo Pharma Inc (QB)
09/09/202212h01Edgar (US Regulatory)Securities Registration Statement (s-1/a)USOTC:SILOSilo Pharma Inc (QB)
29/08/202212h17Edgar (US Regulatory)Securities Registration Statement (s-1/a)USOTC:SILOSilo Pharma Inc (QB)
01/08/202222h02Edgar (US Regulatory)Quarterly Report (10-q)USOTC:SILOSilo Pharma Inc (QB)
25/07/202213h13Edgar (US Regulatory)Securities Registration Statement (s-1/a)USOTC:SILOSilo Pharma Inc (QB)
21/06/202214h05Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:SILOSilo Pharma Inc (QB)
13/05/202222h19Edgar (US Regulatory)Quarterly Report (10-q)USOTC:SILOSilo Pharma Inc (QB)
11/03/202222h04Edgar (US Regulatory)Current Report Filing (8-k)USOTC:SILOSilo Pharma Inc (QB)
07/03/202223h26Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)USOTC:SILOSilo Pharma Inc (QB)
14/02/202223h43Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)USOTC:SILOSilo Pharma Inc (QB)
06/01/202200h19Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)USOTC:SILOSilo Pharma Inc (QB)
15/12/202119h32Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:SILOSilo Pharma Inc (QB)
10/11/202123h15Edgar (US Regulatory)Quarterly Report (10-q)USOTC:SILOSilo Pharma Inc (QB)
27/10/202122h31Edgar (US Regulatory)Current Report Filing (8-k)USOTC:SILOSilo Pharma Inc (QB)
 Showing the most relevant articles for your search:USOTC:SILO